Guangdong Marubi Biotechnology Future Growth
Future criteria checks 4/6
Guangdong Marubi Biotechnology is forecast to grow earnings and revenue by 23.2% and 19.9% per annum respectively. EPS is expected to grow by 23.4% per annum. Return on equity is forecast to be 13% in 3 years.
Key information
23.2%
Earnings growth rate
23.4%
EPS growth rate
Personal Products earnings growth | 20.4% |
Revenue growth rate | 19.9% |
Future return on equity | 13.0% |
Analyst coverage | Good |
Last updated | 16 Jul 2024 |
Recent future growth updates
Recent updates
Investors Could Be Concerned With Guangdong Marubi Biotechnology's (SHSE:603983) Returns On Capital
Jun 19Guangdong Marubi Biotechnology (SHSE:603983) Has A Pretty Healthy Balance Sheet
May 29Are Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983) Investors Paying Above The Intrinsic Value?
May 07Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) Share Price Matching Investor Opinion
Mar 27Guangdong Marubi Biotechnology (SHSE:603983) Will Be Hoping To Turn Its Returns On Capital Around
Feb 29Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 4,217 | 565 | 475 | 673 | 10 |
12/31/2025 | 3,599 | 473 | 383 | 593 | 11 |
12/31/2024 | 2,939 | 377 | 190 | 458 | 11 |
3/31/2024 | 2,410 | 291 | 88 | 374 | N/A |
12/31/2023 | 2,226 | 259 | 78 | 338 | N/A |
9/30/2023 | 2,124 | 228 | -39 | 178 | N/A |
6/30/2023 | 1,974 | 188 | -96 | 113 | N/A |
3/31/2023 | 1,826 | 187 | -34 | 69 | N/A |
12/31/2022 | 1,732 | 174 | -65 | 48 | N/A |
9/30/2022 | 1,793 | 226 | -28 | 122 | N/A |
6/30/2022 | 1,730 | 176 | -83 | 48 | N/A |
3/31/2022 | 1,766 | 213 | -150 | -13 | N/A |
12/31/2021 | 1,787 | 248 | -128 | -7 | N/A |
9/30/2021 | 1,745 | 268 | -627 | 25 | N/A |
6/30/2021 | 1,825 | 385 | -519 | 253 | N/A |
3/31/2021 | 1,779 | 446 | -434 | 319 | N/A |
12/31/2020 | 1,745 | 464 | -387 | 362 | N/A |
9/30/2020 | 1,727 | 494 | 154 | 327 | N/A |
6/30/2020 | 1,780 | 527 | 309 | 339 | N/A |
3/31/2020 | 1,806 | 514 | 372 | 400 | N/A |
12/31/2019 | 1,801 | 515 | 459 | 466 | N/A |
9/30/2019 | 1,732 | 539 | 540 | 544 | N/A |
6/30/2019 | 1,662 | 477 | 557 | 562 | N/A |
3/31/2019 | 1,606 | 440 | 473 | 481 | N/A |
12/31/2018 | 1,576 | 415 | 505 | 517 | N/A |
12/31/2017 | 1,352 | 312 | N/A | 356 | N/A |
12/31/2016 | 1,208 | 232 | N/A | 213 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 603983's forecast earnings growth (23.2% per year) is above the savings rate (2.9%).
Earnings vs Market: 603983's earnings (23.2% per year) are forecast to grow faster than the CN market (22.1% per year).
High Growth Earnings: 603983's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 603983's revenue (19.9% per year) is forecast to grow faster than the CN market (13.6% per year).
High Growth Revenue: 603983's revenue (19.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 603983's Return on Equity is forecast to be low in 3 years time (13%).